In this episode of the podcast, Kyle interviews Joe Tafur, MD, in the first episode of a new series featuring teachers from Vital, our new 12-month certificate program. Tafur discusses Indigenous wisdom and the transpersonal.
www.psychedelicstoday.com
In this episode of the podcast, Kyle and David interview Andrew Penn: nurse practitioner, Associate Clinical Professor, and Co-founder of OPENurses; a professional organization for nurses interested in psychedelic research.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Jonathan Sabbagh, co-founder and CEO of Journey Clinical, which is a telehealth platform that helps approved therapists integrate KAP (and other modalities) into their practices.
www.psychedelicstoday.com
In this episode of the podcast, Joe revisits the topic of religion and psychedelics with a Priest and Rabbi both very interested in using religion to frame the mystical: Rabbi Zac Kamenetz and Episcopal priest, Hunt Priest.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews D.C.-based attorney and Executive Director of the Association of Entheogenic Practitioners, Danny Peterson. They discuss psychedelics, religion, and freedom in the United States.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews 2 hosts of fellow long-running psychedelics podcast, Entheogen: Joe Zap and Kevin W. They discuss the early days of cannabis, Timothy Leary, gurus, conspiracies, and more.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle discuss Colorado possibly legalizing several drugs through the Natural Medicine Healing Act, and CO also establishing guidelines around EMTs and ketamine administration.
www.psychedelicstoday.com
In this episode of the podcast, Joe interviews Ayize Jama-Everett, Courtney Watson, Leticia Brown, and Kufikiri Imara of A Table of Our Own: a for-Black-people by-Black-people psychedelic conference and documentary.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle dive into all things microdosing: Why people are doing it, possible negative effects, how it could work with pain, and more. And they discuss good outcomes in therapy.
www.psychedelicstoday.com
In this episode of the podcast, Kyle interviews Ryan Zurrer, Founder and Managing Director of Vine Ventures, a psychedelic-focused venture fund which just announced an SPV with MAPS called the Regenerative Financing Vine.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, David interviews Co-founder and CMO of Awakn Life Sciences, Dr. Ben Sessa, and then David and Kyle interview Director, CEO, and Chairman of Mydecine Innovations Group, Josh Bartch.
www.psychedelicstoday.com
In this episode, Joe interviews 17-year veteran of federal policy and founder of Healing Equity and Liberation (HEAL) Organization, Micah Haskell-Hoehl. He discusses HEAL's goals and his path to federal policy and psychedelics.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle address some tweets and discuss ketamine and mysticism, then Joe interviews CEO of MINDCURE, Kelsey Ramsden, about MINDCURE's 2 main pieces: iSTRYM and the Desire Project.
www.psychedelicstoday.com
In this episode, Joe and Kyle interview author, James Fadiman, Ph.D. He talks about the birth of transpersonal psychology, microdosing, and his newest book, "Your Symphony of Selves: Discover and Understand More of Who We Are."
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle discuss Mike Tyson and toads, then Joe and David interview Payton Nyquvest of Numinus, who talks about ayahuasca, chronic pain, integration, reciprocity, and psilocybin.
www.psychedelicstoday.com
In this episode, Joe and Kyle interview CEO & Co-founder of Nue Life, Juan Pablo Cappello. He discusses his entrepreneurial past, the psychedelic gold rush, and how Nue Life will use digital phenotyping to personalize health.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and David speak with CEO & Director of BetterLife Pharma, Ahmad Doroudian, about 2-Bromo-LSD, and then David interviews Chief Medical Officer at Wesana Health, Abid Nazeer.
www.psychedelicstoday.com
In this episode, Joe interviews Erica Rex: writer and participant in one of the first trials using psilocybin to treat cancer-related depression. She discusses the study and tells stories of spontaneous mystical experiences.
www.psychedelicstoday.com
In this episode, Joe sits down with three veteran friends for a special Veterans Day episode. They discuss the difficulties of military life, drug use, and how psychedelics have helped them transition back into civilian life.
www.psychedelicstoday.com
In this week's Solidarity Fridays episode, Joe and Kyle briefly check in from Miami to reflect on the Wonderland and Meet Delic conferences they just attended. They also discuss Compass Pathways' recent research outcomes.
www.psychedelicstoday.com
In this episode, Joe and Kyle interview famed anthropologist and author (most notably of The Cosmic Serpent), Jeremy Narby. He discusses anthropology in the Amazon and ayahuasca: the entourage effect, vine-only, DMT, and more.
www.psychedelicstoday.com
In this episode, Joe interviews Dr. Rachel Yehuda: neuroscientist, researcher, Professor and Vice Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai. She discusses research trials and the future of neuroscience.
www.psychedelicstoday.com
In this episode, Joe interviews Adam Strauss: writer, performer, and comedian. Strauss discusses OCD and how he's learned to manage his with psilocybin, which he documents in his one-man show, "The Mushroom Cure."
www.psychedelicstoday.com
In this week’s Solidarity Fridays episode, Joe and Kyle discuss their conflicts with what to do about the recent accusations of abuse against two prominent figures in this space by friend of the show, Will Hall.
www.psychedelicstoday.com
In this episode, Joe sits down with chemist, filmmaker, and science journalist Hamilton Morris. They discuss his time at Vice, PCP, “Hamilton’s Pharmacopeia,” 5-MeO-DMT, and working with perceived enemies for the greater good.